Sign In
Buy DXR
$10.73
+0.375 (+3.62%)
At Close: Jun 03, 2026
New advice issued to dog owners as vomiting virus cases rise
09:25am, Monday, 10'th Feb 2020
There have been nearly 500 cases of the virus which leaves dogs vomiting for days
Here's What We Think About Daxor Corporation's (NYSEMKT:DXR) CEO Pay
04:20pm, Tuesday, 31'st Dec 2019
In 2016 Michael Feldschuh was appointed CEO of Daxor Corporation (NYSEMKT:DXR). First, this article will compare CEO...
Novel Study from Yale University Utilizes Daxor’s Blood Volume Analyzer (BVA-100®) to Uncover Important Mechanism for Drug Empagliflozin
01:00pm, Thursday, 21'st Nov 2019
Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today announces new data from The Yale
Daxor Highlights New Data From Yale University School Of Medicine Presented At American Heart Association Scientific Sessions
12:00am, Thursday, 21'st Nov 2019Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2019
01:00pm, Tuesday, 12'th Nov 2019
NEW YORK, Nov. 12, 2019 -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume.
Read This Before Judging Daxor Corporation's (NYSEMKT:DXR) ROE
11:37am, Tuesday, 29'th Oct 2019
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
MicroCap Rodeo Investor Conference Lineup for October 15 and 16 - 2019
12:00pm, Tuesday, 15'th Oct 2019
AUSTIN, TX / ACCESSWIRE / October 15, 2019 / The MicroCap Rodeo's inaugural event is set for October 15, and 16 th , 2019 in Austin Texas at the Hilton downtown Austin. Focused on the best ideas conce
Daxor to Present at the Inaugural MicroCap Rodeo Investor Conference on October 15, 2019 at 1:30 PM Central Time
12:30pm, Thursday, 10'th Oct 2019
Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, announced that Michael Feldschuh, Chi
Newly Published Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Assessment of Hypertension
12:00pm, Tuesday, 24'th Sep 2019
NEW YORK, Sept. 24, 2019 -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood.
MicroCap Rodeo Investor Conference - October 15 and 16, 2019, Austin Texas
02:15pm, Thursday, 19'th Sep 2019
Company lineup is filling up fast with 50 good names in the microcap markets, as well as some great private and Pre-IPO companies AUSTIN, TX / ACCESSWIRE / September 19, 2019 / The MicroCap Rodeo's in
New Data Presented on Blood Volume at Annual Heart Failure Society Meeting Amid Call to Broadly Adopt Daxor’s Diagnostic Technology
12:00pm, Wednesday, 18'th Sep 2019
Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today announces new data from the Mayo
Daxor Reports 38% Increase In BVA-100 Cardiology Kit Sales, Net Gain Of ~$498K For 6 Months
12:00am, Wednesday, 04'th Sep 2019Daxor Reports Purchase Of BVA-100 Blood Volume Analyzer, No Terms Disclosed
12:00am, Tuesday, 06'th Aug 2019HEATWAVE: Look after your small furries warns top vet - The Wokingham Paper
07:54am, Thursday, 25'th Jul 2019
PETS need extra care during the UK heatwave, warns the British Veterinary Association (BVA)
